2021 Press Releases
April 5, 2021
“Due to the rapidly increasing use of silane quats in a variety of applications, it becomes critical to make methanol-free silane quat antimicrobials available to the market,” said Shiming Wo, Gelest Vice President and General Manager Life Sciences. “At Gelest, we have successfully developed BIOSAFE® HE4005 and HE4001 Antimicrobials using methanol-free processes and obtained the regulatory approvals as antimicrobial preservatives for a broad range of applications including surfaces and materials that come into direct contact with food.”
March 1, 2021
Dr. Barry Arkles, Gelest, Inc. Chair, Founder and CEO, is elected to membership in the National Academy of Engineering (NAE). Election to the NAE is “among the highest professional distinctions accorded to an engineer.” Dr. Arkles is recognized for his “contributions to organosilicon materials and organometallic and biochemical reagents.
February 24, 2021
Gelest, Inc. introduces Vertasil® TM-CBD1, a novel CBD hybrid fluid that that will increase formulation opportunities for personal care. It is the only product on the market that can compatibilize CBD in silicone-based formulations and Polydimethylsiloxane (PDMS) gels.